Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.

MLA

Banys, Malgorzata, et al. “Influence of Zoledronic Acid on Disseminated Tumor Cells in Bone Marrow and Survival: Results of a Prospective Clinical Trial.” BMC Cancer, vol. 13, Oct. 2013, p. 480. EBSCOhost, https://doi.org/10.1186/1471-2407-13-480.

APA

Banys, M., Solomayer, E.-F., Gebauer, G., Janni, W., Krawczyk, N., Lueck, H.-J., Becker, S., Huober, J., Kraemer, B., Wackwitz, B., Hirnle, P., Wallwiener, D., & Fehm, T. (2013). Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. BMC Cancer, 13, 480. https://doi.org/10.1186/1471-2407-13-480

Chicago

Banys, Malgorzata, Erich-Franz Solomayer, Gerhard Gebauer, Wolfgang Janni, Natalia Krawczyk, Hans-Joachim Lueck, Sven Becker, et al. 2013. “Influence of Zoledronic Acid on Disseminated Tumor Cells in Bone Marrow and Survival: Results of a Prospective Clinical Trial.” BMC Cancer 13 (October): 480. doi:10.1186/1471-2407-13-480.